US · MNDR
Mobile-health Network Solutions Class A Ordinary Shares
- Sector
- Healthcare · Medical - Care Facilities
- Headquarters
- Singapore 608526
- Website
- manadr.com
Price · as of 2025-06-30
$0.95
Market cap 823.75K
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $3,450.46 | +363,106.32% |
| Intrinsic Value(DCF) | $1.60 | +68.42% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | $690.87 | +72,623.05% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | $10.33 | $20.93 | |||
| 2023 | $0.00 | $0.00 | |||
| 2024 | $31.20 | $719.55 | $82,777.70 | $0.00 | $0.00 |
| 2025 | $4.00 | $3,450.46 | $0.00 | $0.00 | $690.87 |
AI valuation
Our deep-learning model estimates Mobile-health Network Solutions Class A Ordinary Shares's (MNDR) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $3,450.46
- Current price
- $0.95
- AI upside
- +363,106.32%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$1.60
+68.42% upside
Graham-Dodd
—
— upside
Graham Formula
$690.87
+72,623.05% upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| MNDR | Mobile-health Network Sol… | $0.95 | 823.75K | +363,106% | +68% | — | +72,623% | -0.28 | 0.34 | 0.12 | -0.06 | — | 3.53 | -11.45% | -46.36% | -44.25% | -82.47% | 729.66% | -44.64% | 0.12 | — | 1.06 | 0.89 | 0.23 | -3577.00% | -5868.00% | -4896.00% | -471.04% | -2.48 | 910.23% | 0.00% | 0.00% | 0.00% | -0.05 | -0.04 | 0.02 | -9.41 |
| AIMD | Ainos, Inc. | $1.64 | 7.91M | +1,477% | -27% | — | +6,696% | -1.56 | 1.50 | 1120.96 | -3.32 | — | -2.82 | -153.73% | -66772.17% | -71702.26% | -74.38% | -53.08% | -49.00% | 0.77 | -22.45 | 1.10 | 0.98 | -0.86 | -5357.00% | -8302.00% | 2176.00% | -25.09% | -1.47 | -22.36% | 0.00% | 0.00% | 0.00% | -2.26 | -5.38 | 1512.06 | -3.08 |
| ARTL | Artelo Biosciences, Inc. | $1.19 | 2.75M | — | — | — | — | -0.09 | -0.92 | — | -0.10 | -0.03 | -0.35 | 0.00% | — | — | -1625.11% | 4102.16% | -343.49% | -0.54 | -58.78 | 0.17 | 0.15 | -0.01 | 31049.00% | — | 204.00% | -726.31% | -2.11 | 3064.75% | 0.00% | 0.00% | 0.00% | -0.11 | -0.15 | — | -46.19 |
| BIAF | bioAffinity Technologies,… | $1.06 | 4.77M | +8,873% | +321% | — | — | -0.50 | 1.73 | 0.48 | -0.59 | — | 10.68 | 36.09% | -95.63% | -96.56% | -242.44% | -270.88% | -122.70% | 0.58 | -96.82 | 0.87 | 0.72 | -0.05 | -1758.00% | 26975.00% | 2117.00% | -162.75% | -2.34 | -222.20% | 0.00% | 0.00% | 0.00% | -0.55 | -0.67 | 0.52 | -14.01 |
| GTBP | GT Biopharma, Inc. | $0.48 | 5.08M | — | — | — | — | -0.35 | -2.77 | — | -0.05 | -1.53 | -2.77 | 0.00% | — | — | -453.39% | 238.23% | -143.53% | 0.00 | — | 0.72 | 0.67 | 0.30 | 2305.00% | — | 4577.00% | -278.78% | -2.19 | 214.01% | 0.00% | 0.00% | 63.30% | -0.05 | -0.05 | — | -241.19 |
| PBM | Psyence Biomedical Ltd. | $2.54 | 48.31K | — | — | — | — | 121.05 | 18.22 | — | 113.47 | — | 18.22 | 0.00% | — | — | -47.61% | 1045.66% | 23.95% | 0.00 | -395.15 | 11.04 | 10.55 | -5.98 | -12268.00% | — | 2687.00% | -3.06% | -6.28 | 1068.81% | 0.00% | 0.00% | 12.94% | -31.76 | -31.07 | — | 112.16 |
| PTIX | Protagenic Therapeutics, … | $0.47 | 896.47K | — | — | — | — | -4.00 | 21.80 | — | -3.70 | — | 21.80 | 0.00% | — | — | -236.06% | 939.82% | -175.99% | 0.00 | — | 2.00 | 1.95 | 0.34 | -174.00% | — | 942.00% | -19.09% | -4.47 | 695.10% | 0.00% | 0.00% | 2.49% | -3.55 | -4.80 | — | -20.97 |
| REVB | Revelation Biosciences, I… | $1.32 | 1.95M | — | — | — | — | 0.00 | 0.00 | — | 0.67 | — | 0.00 | 0.00% | — | — | -201.08% | 1657.76% | -153.82% | 0.08 | — | 5.41 | 5.36 | 0.67 | -7268.00% | — | 4498931.00% | -103262.37% | -4.14 | 1511.33% | 74316.81% | -66.80% | 198525.74% | 1.10 | 1.20 | — | -7.64 |
| WOK | WORK Medical Technology G… | $1.34 | 7.64K | +123,574,441% | +122,210% | +334,198% | +155,787% | -1.41 | 0.08 | 0.15 | 11.42 | -0.11 | 0.09 | 23.81% | -25.34% | -10.89% | -6.80% | -12.24% | -3.09% | 0.35 | -4.96 | 1.71 | 1.38 | 6.95 | 127074.00% | -1441.00% | -14276.00% | 324.07% | 0.52 | 24.08% | 0.00% | 0.00% | 300.12% | -1.55 | 0.79 | 0.39 | 0.64 |
About Mobile-health Network Solutions Class A Ordinary Shares
Mobile-health Network Solutions, an investment holding company, provides telehealth solutions in Singapore. The company operates in two segments, Telemedicine and Other Services, and Sale of Medicine and Medical Devices. It offers MaNaDr platform, a 360-degree healthcare ecosystem, which connects users and service providers through the range of healthcare services and product offerings that can be accessed through the mobile application and website. The company also provides a range of primary healthcare services, including general medical consultations, treatment and management of acute and chronic conditions in adults and children, vaccinations, and health screenings for work permit applications, as well as pre-employment health screening, children's health services, geriatric care services, and minor surgical procedures. In addition, it offers healthcare and wellness-related products through its online e-commerce platform; wholesale distribution of pharmaceutical products to clinics; and MaNaCare, a platform that provides a range of corporate healthcare and wellness services, including GP, specialist and allied healthcare panel services, tele-consultation services, in-person clinics, on-site health screening, and online marketplace and forum, as well as wellness programs to corporate customers. Further, the company develops IT systems on mobile phone and web portals; operates pharmacies, clinics, and drug stores; and offers beauty and other personal care services, as well as other general medical and health services. The company was founded in 2009 and is headquartered in Singapore.
- CEO
- Pui Pui Teoh
- Employees
- 73
- Beta
- -2.16
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($1.60 ÷ $0.95) − 1 = +68.42% (DCF, example).